PMHNP-BC LMR Study Guide: Updated 2025/2026 Syllabus
Disclaimer: This guide is a supplementary study tool. It is essential to use official board
review materials, textbooks, and current clinical guidelines (e.g., APA, ISBD) for complete
preparation. The "LMR" (Learn, Memorize, Recite) format is designed for active recall.
Section 1: Neuroscience & Psychopharmacology
1. A patient with Major Depressive Disorder (MDD) has failed two adequate trials
of SSRIs. You are considering a medication with a different mechanism. Which of
the following works primarily as a serotonin modulator and stimulator (SMS) and
a serotonin receptor antagonist?
ANSWER ✓ Vortioxetine (Trintellix). It inhibits the serotonin transporter (SERT) while
also acting as an agonist/antagonist at various serotonin receptors (5-HT1A, 5-HT1B, 5-
HT1D, 5-HT3), which is thought to contribute to its pro-cognitive effects.
2. What is the primary mechanism of action of Pimavanserin (Nuplazid), used for
Parkinson's disease psychosis?
ANSWER ✓ It is a potent inverse agonist and antagonist at serotonin 5-HT2A receptors,
with low affinity for dopamine receptors. This unique profile avoids worsening motor
symptoms, unlike typical or atypical antipsychotics.
3. A patient on Valproic Acid for bipolar disorder presents with tremors, ataxia,
and lethargy. Lab tests show an elevated ammonia level with normal Valproic Acid
levels. What is the most appropriate intervention?
ANSWER ✓ This suggests Valproate-Induced Hyperammonemic Encephalopathy. The
intervention is to discontinue Valproic Acid and administer L-Carnitine, which helps
detoxify ammonia and restore mitochondrial function.
4. What is the key pharmacodynamic difference between a typical and an atypical
antipsychotic?
ANSWER ✓ While both block D2 dopamine receptors, atypical antipsychotics have a
higher ratio of serotonin 5-HT2A receptor blockade to D2 blockade. This is associated
, with a lower risk of extrapyramidal symptoms (EPS) and greater efficacy for negative
symptoms.
5. Which mood stabilizer is considered a first-line treatment for acute mania and
also has evidence for neuroprotective properties, potentially increasing gray
matter volume?
ANSWER ✓ Lithium. Its neuroprotective effects are linked to the inhibition of glycogen
synthase kinase-3 (GSK-3) and increased brain-derived neurotrophic factor (BDNF).
6. What is the mechanism of action of Cariprazine (Vraylar), and how does it
explain its utility in both bipolar I and adjunctive MDD?
ANSWER ✓ Cariprazine is a dopamine D3-preferring D3/D2 receptor partial agonist. Its
high affinity for D3 receptors, which are involved in motivation and reward pathways,
may underpin its efficacy for the negative symptoms of schizophrenia and anhedonia in
depression.
7. Why must a patient be screened for the HLA-B*1502 allele before starting
Carbamazepine, particularly in those of Asian descent?
ANSWER ✓ The presence of the HLA-B*1502 allele is strongly associated with an
increased risk of developing severe and potentially fatal dermatologic reactions,
including Stevens-Johnson Syndrome (SJS) and Toxic Epidermal Necrolysis (TEN).
8. What is the primary reason Lamotrigine requires a very slow titration schedule?
ANSWER ✓ To significantly reduce the risk of serious, life-threatening rashes, including
SJS and TEN. A slow titration allows the immune system to develop tolerance.
9. Which antidepressant is a triple reuptake inhibitor (Serotonin, Norepinephrine,
and Dopamine) and is also a Schedule IV controlled substance?
ANSWER ✓ Levomilnacipran (Fetzima) is an SNRI, but it is not a triple reuptake inhibitor.
The correct answer is Bupropion (Wellbutrin) is a DNRI (Dopamine and
Norepinephrine Reuptake Inhibitor). There is no widely approved triple reuptake
inhibitor in the US. The scheduled substance with dopaminergic action is Bupropion, but
it does not affect serotonin.
10. What is the role of the enzyme CYP2D6 in pharmacogenetics, and name one
key antidepressant it metabolizes.
Disclaimer: This guide is a supplementary study tool. It is essential to use official board
review materials, textbooks, and current clinical guidelines (e.g., APA, ISBD) for complete
preparation. The "LMR" (Learn, Memorize, Recite) format is designed for active recall.
Section 1: Neuroscience & Psychopharmacology
1. A patient with Major Depressive Disorder (MDD) has failed two adequate trials
of SSRIs. You are considering a medication with a different mechanism. Which of
the following works primarily as a serotonin modulator and stimulator (SMS) and
a serotonin receptor antagonist?
ANSWER ✓ Vortioxetine (Trintellix). It inhibits the serotonin transporter (SERT) while
also acting as an agonist/antagonist at various serotonin receptors (5-HT1A, 5-HT1B, 5-
HT1D, 5-HT3), which is thought to contribute to its pro-cognitive effects.
2. What is the primary mechanism of action of Pimavanserin (Nuplazid), used for
Parkinson's disease psychosis?
ANSWER ✓ It is a potent inverse agonist and antagonist at serotonin 5-HT2A receptors,
with low affinity for dopamine receptors. This unique profile avoids worsening motor
symptoms, unlike typical or atypical antipsychotics.
3. A patient on Valproic Acid for bipolar disorder presents with tremors, ataxia,
and lethargy. Lab tests show an elevated ammonia level with normal Valproic Acid
levels. What is the most appropriate intervention?
ANSWER ✓ This suggests Valproate-Induced Hyperammonemic Encephalopathy. The
intervention is to discontinue Valproic Acid and administer L-Carnitine, which helps
detoxify ammonia and restore mitochondrial function.
4. What is the key pharmacodynamic difference between a typical and an atypical
antipsychotic?
ANSWER ✓ While both block D2 dopamine receptors, atypical antipsychotics have a
higher ratio of serotonin 5-HT2A receptor blockade to D2 blockade. This is associated
, with a lower risk of extrapyramidal symptoms (EPS) and greater efficacy for negative
symptoms.
5. Which mood stabilizer is considered a first-line treatment for acute mania and
also has evidence for neuroprotective properties, potentially increasing gray
matter volume?
ANSWER ✓ Lithium. Its neuroprotective effects are linked to the inhibition of glycogen
synthase kinase-3 (GSK-3) and increased brain-derived neurotrophic factor (BDNF).
6. What is the mechanism of action of Cariprazine (Vraylar), and how does it
explain its utility in both bipolar I and adjunctive MDD?
ANSWER ✓ Cariprazine is a dopamine D3-preferring D3/D2 receptor partial agonist. Its
high affinity for D3 receptors, which are involved in motivation and reward pathways,
may underpin its efficacy for the negative symptoms of schizophrenia and anhedonia in
depression.
7. Why must a patient be screened for the HLA-B*1502 allele before starting
Carbamazepine, particularly in those of Asian descent?
ANSWER ✓ The presence of the HLA-B*1502 allele is strongly associated with an
increased risk of developing severe and potentially fatal dermatologic reactions,
including Stevens-Johnson Syndrome (SJS) and Toxic Epidermal Necrolysis (TEN).
8. What is the primary reason Lamotrigine requires a very slow titration schedule?
ANSWER ✓ To significantly reduce the risk of serious, life-threatening rashes, including
SJS and TEN. A slow titration allows the immune system to develop tolerance.
9. Which antidepressant is a triple reuptake inhibitor (Serotonin, Norepinephrine,
and Dopamine) and is also a Schedule IV controlled substance?
ANSWER ✓ Levomilnacipran (Fetzima) is an SNRI, but it is not a triple reuptake inhibitor.
The correct answer is Bupropion (Wellbutrin) is a DNRI (Dopamine and
Norepinephrine Reuptake Inhibitor). There is no widely approved triple reuptake
inhibitor in the US. The scheduled substance with dopaminergic action is Bupropion, but
it does not affect serotonin.
10. What is the role of the enzyme CYP2D6 in pharmacogenetics, and name one
key antidepressant it metabolizes.
